Mannkind (MNKD) Research & Development (2010 - 2026)
Mannkind's Research & Development came in at $18 million for Q2 2026, up 31.6% from $13.68 million a year earlier and up 4.5% from the prior quarter.
Mannkind (MNKD) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Mannkind reported Research & Development of $76.88 million, up 57.7% year-over-year; for FY2025, it came in at $66.35 million, up 44.6% from FY2024.
- Research & Development has increased in each of the last five years, with a five-year compound annual growth rate of 60.4% (FY2020 to FY2025).
- Going back by year, Research & Development was $45.89 million in FY2024 (+46.7%), $31.28 million in FY2023 (+58.6%), $19.72 million in FY2022 (+60.2%) and $12.31 million in FY2021 (+97.1%).
- The five-year range for quarterly Research & Development is $3.54 million (Q1 2022) to $27.59 million (Q4 2025).
- Year-over-year, Research & Development has increased for 22 consecutive quarters, with growth averaging 40.0% over the last eight quarters.
- Over the past five years, the year-over-year growth in Research & Development ranged from 8.8% (Q3 2025) to 151.5% (Q4 2021).
- Business Quant data shows MNKD's Research & Development at $17.23 million (Q1 2026), $27.59 million (Q4 2025) and $14.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Mannkind | 949.22 Mn | 269.86 Mn | 94.97 Mn | 18.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.00 Mn |
| Mar 31, 2026 | 17.23 Mn |
| Dec 31, 2025 | 27.59 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Jun 30, 2025 | 13.68 Mn |
| Mar 31, 2025 | 11.02 Mn |
| Dec 31, 2024 | 11.14 Mn |
| Sep 30, 2024 | 12.93 Mn |
| Jun 30, 2024 | 11.82 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | 9.24 Mn |
| Sep 30, 2023 | 9.99 Mn |
| Jun 30, 2023 | 6.45 Mn |
| Mar 31, 2023 | 5.61 Mn |
| Dec 31, 2022 | 7.16 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 3.66 Mn |
Mannkind Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MNKD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MNKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MNKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();